Government
of Pakistan
Ministry
of National Health Services, Regulations & Coordination
Drug Regulatory Authority of
Pakistan
Division
of Pharmaceutical Evaluation & Registration
CTD PRE-SUBMISSION SCREENING
CHECKLIST
Note: Application shall be received
for detailed evaluation if all the below mentioned documents are submitted.
Complete Form 5-F along with
commitments attached:
|
||
Requisite fee submitted:
|
||
Valid DML / DSL is attached:
|
||
Sectional approval letter is attached:
|
||
Valid GMP inspection report is
attached:
|
||
Evidence of international
availability in RRA is provided:
|
||
All summaries are provided in
Module-2 instead of referring to Module 3:
|
||
For
Module-3, in Drug Substance part:
|
||
3.2.S.2: Manufacturer(s) along
with evidence of local purchase / import:
|
||
3.2.S.7: Stability data of 3
batches as per zone IV-A:
|
||
For
Module-3, in Drug Product part:
|
||
3.2.P.2.2.1: Pharmaceutical
Equivalence through Comparative Dissolution Profile (where applicable) along
with evidence of purchase of reference product
|
||
3.2.P.3.5: Process validation and
/or evaluation
|
||
3.2.P.5.3: Validation of
analytical procedures (in case of non-pharmacopoeial drugs)
|
||
3.2.P.8.3: Stability data
|
||
FOR IMPORTED PRODUCTS (Following
additional documents)
|
||
Original, legalized and valid CoPP
/ Free sale and GMP certificate
|
||
Sole agency agreement /
authorization letter
|
||
Credentials of the manufacturer /
site master file
|
||
FOR CONTRACT MANUFACTURING
(Following additional documents)
|
||
Contract manufacturing agreement
|
||
Details of already approved
products for contract manufacturing
|
||
Remarks
(if any):
____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________






0 Comments:
Post a Comment